LLaminar Pharma — Unstaged equity · €2M
In 2022 Laminar raised €2M, the legal maximum, through an equity crowdfunding campaign on Capital Cell. The date shown is the company's year-end announcement (14 Dec 2022); the campaign's own close date was not found. The company raised €6M across several rounds that year: the other €4M came from private investors, including the Matutes family office Residencial Es Vivé, and its shareholder base grew to more than 1,700.
Lead unknown
RoundUnstaged equity
Announced14 Dec 2022
CityPalma de Mallorca
SectorHealthtech & Bio · Biotech / Pharma
Source
L
L
The company
Investors
No investors were disclosed for this round.